SCHEMBL4661541

SCHEMBL4661541

C=C(C)C(=O)OC(CC)C([SiH3])(c1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.43
ELANE P08246 1/20 0.36
MAPT P10636 2/20 0.34
ALDH1A1 P00352 1/20 0.34
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
KIF11 P52732 4/20 0.33
KCNN4 O15554 1/20 0.33
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14938033 0.74 ALDH1A1 (0.43) MAPTALDH1A1MEN1GAAKMT2A
SCHEMBL7025018 0.73 TSHR (0.36) ALDH1A1
SCHEMBL14843056 0.73 ELANE (0.35) KCNH2ELANEMAPTALDH1A1KIF11
SCHEMBL10062523 0.73 ELANE (0.42) KCNH2ELANEHTT
Hydrochloric Acid SCHEMBL3899766 0.72 MAPT (0.37) KCNH2ELANEMAPTALDH1A1KDM4E
SCHEMBL584058 0.72 ALDH1A1 (0.38) ALDH1A1
SCHEMBL47310 0.72 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL23494164 0.72 TSHR (0.37) KCNH2ALDH1A1
SCHEMBL20924713 0.71 ALDH1A1 (0.41) ALDH1A1KMT2ASMN1; SMN2
SCHEMBL2231481 0.71 KCNH2 (0.36) KCNH2ELANEMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444239-B1 HIGH REFRACTIVE INDEX AROMATIC-BASED SILYL MONOMERS BAUSCH & LOMB (US) 2008-12-24 EP disclosed
US-7132494-B2 High refractive index aromatic-based silyl monomers BAUSCH & LOMB INCORPORATED (US) 2006-11-07 US disclosed
US-6881809-B2 High refractive index aromatic-based silyl monomers BAUSCH & LOMB INCORPORATED (US) 2005-04-19 US disclosed
US-6846897-B2 High refractive index aromatic-based silyl monomers BAUSCH AND LOMB, INC. (US) 2005-01-25 US disclosed
US-20040230023-A1 High refractive index aromatic-based silyl monomers SALAMONE JOSEPH C (US) 2004-11-18 US disclosed
US-20040215156-A1 High refractive index aromatic-based silyl monomers SOLTA MEDICAL, INC. 2004-10-28 US disclosed
US-20040215032-A1 High refractive index aromatic-based silyl monomers SALAMONE JOSEPH C 2004-10-28 US disclosed
US-20040210023-A1 High refractive index aromatic-based silyl monomers SALAMONE JOSEPH C (US) 2004-10-21 US disclosed
EP-1444239-A1 HIGH REFRACTIVE INDEX AROMATIC-BASED SILYL MONOMERS BAUSCH & LOMB INCORPORATED (US) 2004-08-11 EP disclosed
US-6762271-B2 INTRAOCULAR LENSES, CONTACT LENSES AND CORNEAL INLAYS BAUSCH & LOMB INCORPORATED 2004-07-13 US disclosed
US-20030105255-A1 High refractive index aromatic-based silyl monomers BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC. (CA) 2003-06-05 US disclosed
WO-2003040152-A1 HIGH REFRACTIVE INDEX AROMATIC-BASED SILYL MONOMERS BAUSCH & LOMB INCORPORATED (US) 2003-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040215032-A1 High refractive index aromatic-based silyl monomers SMAD2, SMAD3, FHIT KCNH2 2237/4885ELANE 4250/4885MAPT 1090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.